Our group has ongoing efforts to engage with payers to educate them about how
genomic tests work and their potential consequences for patients, physicians, and health care systems.
In addition to much needed conservation efforts, Detwiler and her team also are
working to solve the evolutionary puzzle of the Dryas monkey using
genomic research to
test the hypothesis that this species is a close relative of the Vervet monkey.
The objectives to achieve within the 4 years of the NAREB project are: 1 / to select antibacterial molecules and design nanocarriers with strong antibacterial activity, 2 / to
test in vitro and in vivo the best therapeutic combinations including innovative
genomic and bioimaging approaches, 3 / to assess safety, regulatory and production (GLP / GMP) aspects for the most promising nanoformulations, and 4 / to establishing the Clinical Development Plan for the preparatory
work for the subsequent clinical
testing of the selected nanoformulations.